Description: China Everbright Limited, through its subsidiaries, engages in the investment activities and provision of financial services in Hong Kong and Mainland China. The company invests in unlisted equity securities or equity derivatives, as well as in the areas of new economy, artificial intelligence and advanced manufacturing, new energy, medical care and senior healthcare, overseas acquisition and infrastructure, real estate, aircraft industry chain, mezzanine fund, and others. It also focuses on investing in aircraft leasing, artificial intelligence of things, and elderly care industry platforms; and investing in equity, debts, structured products, and other products. In addition, the company provides a range of financial services, including asset management, investment management, and investment advisory services related to absolute return funds, bond funds, and equity funds, as well as offers management, treasury management, secretarial, money lending, fund management, venture capital, leasing, and consultancy services. The company was founded in 1997 and is headquartered in Hong Kong. China Everbright Limited is a subsidiary of Honorich Holdings Limited.
Home Page: www.everbright.com
Far East Finance Centre
Hong Kong,
Hong Kong
Phone:
852 2528 9882
Officers
| Name | Title |
|---|---|
| Mr. Mingao Zhang | Pres & Exec. Director |
| Mr. Hongyang Wang | VP & Exec. Director |
| Mr. Yanwu Yin | VP & Exec. Director |
| Mr. Zhao Zehui | Sr. Investment Director |
| Mr. Ming Kin Chan | Gen. Counsel |
| Ms. Kim Ying Wan | Company Sec. and Director of Company Secretarial of Legal, Compliance & Company Secretarial |
| Ms. Shengyan Fan | MD of M&A Department & Managing Partner of CEL Catalyst China Israel Fund |
| Mr. John Chan | MD of M&A Department & Managing Partner of CEL Catalyst China Israel Fund |
| Ms. Jane Zhang | Managing Director of Fund of Funds Investment Team |
| Mr. Yizhe Wang | Managing Director of Super Acquisition Fund Department II |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 3.559 |
| Price-to-Book MRQ: | 0.1817 |
| Price-to-Sales TTM: | 3.4885 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 273 |